{"entity":{"type":"insider","cik":"0001779707","url":"/insider/0001779707","json_url":"/insider/0001779707.json","name":"Van Tuyl Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2025-12-19","last":"2026-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Van Tuyl Christopher","source":"filing","n_filings":6,"first_seen":"2025-12-19","last_seen":"2026-07-10"}],"transactions":[{"id":6158959,"accession":"0001764013-26-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-26-000082","line_url":"/filing/0001764013-26-000082#line-2","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1143.0,"shares_display":"1,143","price_per_share":39.53,"price_display":"39.53","price_state":"stated","total_value":45182.79,"total_display":"45,182.79","shares_owned_after":179454.0,"shares_owned_after_display":"179,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-10","scope":"insider"},{"id":6158955,"accession":"0001764013-26-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-26-000082","line_url":"/filing/0001764013-26-000082#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63.0,"shares_display":"63","price_per_share":39.99,"price_display":"39.99","price_state":"stated","total_value":2519.37,"total_display":"2,519.37","shares_owned_after":179391.0,"shares_owned_after_display":"179,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-10","scope":"insider"},{"id":5849461,"accession":"0001764013-26-000073","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001764013-26-000073","line_url":"/filing/0001764013-26-000073#line-3","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14982.0,"shares_display":"14,982","price_per_share":38.19,"price_display":"38.19","price_state":"stated","total_value":572162.58,"total_display":"572,162.58","shares_owned_after":183439.0,"shares_owned_after_display":"183,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider"},{"id":5849460,"accession":"0001764013-26-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-26-000073","line_url":"/filing/0001764013-26-000073#line-2","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2842.0,"shares_display":"2,842","price_per_share":38.96,"price_display":"38.96","price_state":"stated","total_value":110724.32,"total_display":"110,724.32","shares_owned_after":180597.0,"shares_owned_after_display":"180,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider"},{"id":5923697,"accession":"0001779707-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001779707-26-000006","line_url":"/filing/0001779707-26-000006#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2634.0,"shares_display":"2,634","price_per_share":35.39,"price_display":"35.39","price_state":"stated","total_value":93217.26,"total_display":"93,217.26","shares_owned_after":180597.0,"shares_owned_after_display":"180,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-18","filed_date":"2026-06-22","scope":"insider"},{"id":6046770,"accession":"0001779707-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001779707-26-000004","line_url":"/filing/0001779707-26-000004#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5165.0,"shares_display":"5,165","price_per_share":24.83,"price_display":"24.83","price_state":"stated","total_value":128246.95,"total_display":"128,246.95","shares_owned_after":183231.0,"shares_owned_after_display":"183,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-10","scope":"insider"},{"id":5747295,"accession":"0001764013-26-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-26-000015","line_url":"/filing/0001764013-26-000015#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2877.0,"shares_display":"2,877","price_per_share":24.97,"price_display":"24.97","price_state":"stated","total_value":71838.69,"total_display":"71,838.69","shares_owned_after":147053.0,"shares_owned_after_display":"147,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-20","scope":"insider"},{"id":4932481,"accession":"0001764013-25-000163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-25-000163","line_url":"/filing/0001764013-25-000163#line-2","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8529.0,"shares_display":"8,529","price_per_share":26.78,"price_display":"26.78","price_state":"stated","total_value":228406.62,"total_display":"228,406.62","shares_owned_after":152214.0,"shares_owned_after_display":"152,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"},{"id":4932478,"accession":"0001764013-25-000163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000163","line_url":"/filing/0001764013-25-000163#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001779707","owner_name":"Van Tuyl Christopher","owner_url":"/insider/0001779707","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2284.0,"shares_display":"2,284","price_per_share":27.38,"price_display":"27.38","price_state":"stated","total_value":62535.92,"total_display":"62,535.92","shares_owned_after":149930.0,"shares_owned_after_display":"149,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Officer (Chief Legal Officer)","n_filings":6,"first_seen":"2025-12-19","last_seen":"2026-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001779707","retrieved_at":"2026-08-21T15:31:01+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}